|
answer text |
<p>The Government has noted the importance of continued collaboration with European
partners in the 2017 policy paper ‘Collaboration on Science and Innovation: A Future
Partnership Paper’. European Reference Networks (ERNs) for rare diseases patients
were cited in the paper as an example of collaboration that the United Kingdom and
European Union should discuss in the negotiations, given the mutual benefit.</p><p>
</p><p>The Government has set out three key principles in developing a new regulatory
system post EU exit: patients should not be disadvantaged; innovators should be able
to get their products into the UK market as quickly and simply as possible; and we
continue to play a leading role promoting public health. The Government will be guided
by these principles in its negotiations with EU partners.</p>
|
|